The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Abstract
The diagnosis and treatment of neurological ailments always remain an utmost challenge for research fraternity due to the presence of BBB. The intranasal route appeared as an attractive and alternative route for brain targeting of therapeutics without the intrusion of BBB and GI exposure. This route directly and effectively delivers the therapeutics to different regions of the brain via olfactory and trigeminal nerve pathways. However, shorter drug retention time and mucociliary clearance curtail the efficiency of the intranasal route. The in situ mucoadhesive gel overthrow the limitations of direct nose-to-brain delivery by not only enhancing nasal residence time but also minimizing the mucociliary clearance and enzymatic degradation. This delivery system further improves the nasal absorption as well as bioavailability of drugs in the brain. The in situ mucoadhesive gel is a controlled and sustained release system that facilitates the absorption of various proteins, peptides and other larger lipophilic and hydrophilic moieties. Owing to multiple benefits, in situ gelling system has been widely explored to target the brain via nasal route. However, very few review works are reported which explains the application of in situ nasal gel for brain delivery of CNS acting moieties. Hence, in this piece of work, we have initially discussed the global statistics of neurological disorders reported by WHO and other reputed organizations, nasal anatomy, mechanism and challenges of nose-to-brain drug delivery. The work mainly focused on the use of different stimuli-responsive polymers, specifically thermoresponsive, pH-responsive, and ion triggered systems for the development of an effective and controlled dosage form, i.e., in situ nasal gel for brain targeting of bioactives. We have also highlighted the origin, structure, nature and phase transition behavior of the smart polymers found suitable for nasal administration, including poloxamer, chitosan, EHEC, xyloglucan, Carbopol, gellan gum and DGG along with their application in the treatment of neurological disorders. The article is aimed to gather all the information of the past 10 years related to the development and application of stimuli-responsive in situ nasal gel for brain drug delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–220 of 220
Calejo, M. T., Kjøniksen, A., Pinazo, A., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.018 · Cited by 34
Kumar, P., Sharma, G., Kumar, R., Malik, R., Singh, B., Katare, O. P., & Raza, K. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0082 · Cited by 34
Self-citationAlexander, A., Ajazuddin, M., Khan, J. A., et al. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12262 · Cited by 33
Self-citationImproving mechanical properties of injectable polymers and composites
Qiu, Y., Hamilton, S. K., & Temenoff, J. S. (2011) · Elsevier eBooks · doi:10.1533/9780857091376.1.61 · Cited by 30
Altamura, A. C., Moliterno, D., Paletta, S., Buoli, M., Dell’Osso, B. M., Mauri, M. C., & Bareggi, S. R. (2012) · Clinical Drug Investigation · doi:10.2165/11597330-000000000-00000 · Cited by 30
In situ thermo-co-electroresponsive mucogel for controlled release of bioactive agent
Akilo, O. D., Kumar, P., Choonara, Y. E., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.044 · Cited by 29
Self-citationSelegiline in Parkinson's disease
Calne, D. B. (1995) · BMJ · doi:10.1136/bmj.311.7020.1583 · Cited by 25
Pawar, G. N., Parayath, N. N., Nocera, A. L., Bleier, B. S., & Amiji, M. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208122 · Cited by 25
Alexander, A., Saraf, S., & Saraf, S. (2016) · Current Drug Delivery · doi:10.2174/1567201813666160204114000 · Cited by 21
Self-citationEllermann, C., Coenen, A., Niehues, P., Leitz, P. R., Kochhäuser, S., Dechering, D. G., Fehr, M., Eckardt, L., & Frommeyer, G. (2019) · Cardiovascular Toxicology · doi:10.1007/s12012-019-09543-8 · Cited by 21
Nazar, H., Roldo, M., Fatouros, D. G., van der Merwe, S. M., & Tsibouklis, J. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.16 · Cited by 20
Buchwald, P., & Bodor, N. S. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.04.007 · Cited by 19
Dubey, S. K., Alexander, A., Munnangi, S. R., Agrawal, M., Singhvi, G., Sharma, S. K., & Dayaramani, R. A. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200103124821 · Cited by 16
Self-citationK V, A., Madhana, R. M., Bais, A. K., Singh, V. B., Malik, A., Sinha, S., Lahkar, M., Kumar, P., & Samudrala, P. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00315 · Cited by 15
Self-citationEsposti, L. D., Piccinni, C. P., Sangiorgi, D., Nobili, F. M., & Buda, S. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2395-7 · Cited by 15
PREPARATION AND EVALUATION OF INTRAORAL DRUG DELIVERY SYSTEM FOR RASAGILINE MESYLATE
Bukka, R., Prakasam, K., & Patel, C. D. (2010) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2010.020415 · Cited by 14
Harrison, C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3935 · Cited by 10
Bypassing the blood–brian barrier using established skull base reconstruction techniques
Miyake, M. M., & Bleier, B. S. (2015) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1016/j.wjorl.2015.09.001 · Cited by 10
Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
Kohman, R. E., Han, X., & Bleier, B. S. (2014) · Journal of Visualized Experiments · doi:10.3791/51452 · Cited by 5
Nanotechnology: A non-invasive diagnosis and therapeutic tool for brain disorders
Amit, A., Sabahuddin, S., Mukta, A., Ajazuddin, M., Ahmed, M. S., Mahmoud, A. S., Syed, A. U. R., Mohi, I. M. A., & Mohamed, A. S. (2019) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2019.5008 · Cited by 3
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Overcoming barriers by local drug delivery with liposomes
Antimisiaris, S. G., Marazioti, A., Kannavou, M., Natsaridis, E., Gkartziou, F., Kogkos, G., & Mourtas, S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.019 · Cited by 339
On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
Formica, M. L., Real, D. A., Picchio, M. L., Catlin, E., Donnelly, R. F., & Paredes, A. J. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101631 · Cited by 282
Koo, J., Lim, C., & Oh, K. T. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s439181 · Cited by 174
Metadata
- Authors
- Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., Murty, U. S., Ajazuddin, & Alexander, A.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 327
- Pages
- 235-265
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W3046258544
- Cited by
- 298
- References
- 220
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.